@phulicia's estradiol dose adjustment claims, fact-checked

TikTok creator @phulicia shared an update about her bloodwork after reducing her estradiol dose to 0.10 ml. The video touches on hormone monitoring during transgender hormone therapy, though it lacks specific lab values or clinical context that would help viewers understand the changes.

What does this video actually claim?

@phulicia reports getting updated lab results after cutting her estradiol dose to 0.10 ml (she corrects herself from initially saying "mg"). She mentions this is an update on her bloodwork but doesn't share specific values or what prompted the dose reduction.

The video is brief and mainly serves as a progress update for her followers. She thanks viewers for support and uses hashtags related to transgender hormone therapy and MTF (male-to-female) transition.

Without seeing the actual lab values or knowing her baseline measurements, it's impossible to evaluate whether her dose adjustment was appropriate or what changes occurred.

How does estradiol dosing actually work?

Estradiol dosing in transgender women typically aims for serum levels between 100-200 pg/ml, though some guidelines suggest up to 300 pg/ml during the first year of treatment. The WPATH Standards of Care recommend monitoring estradiol levels every 3 months during the first year.

Injectable estradiol valerate or cypionate doses usually range from 2-10 mg every 1-2 weeks, depending on the concentration and individual response. A volume of 0.10 ml could represent different actual doses depending on the concentration (typically 20 mg/ml or 40 mg/ml).

The Endocrine Society guidelines (Hembree et al., Journal of Clinical Endocrinology & Metabolism, 2017) emphasize individualizing doses based on clinical response and hormone levels, not just following a standard protocol.

What's missing from this update?

@phulicia's video lacks the specific information that would make it useful for viewers trying to understand hormone management. She doesn't share her actual estradiol levels, what they were before the dose change, or why the reduction was needed.

This matters because high estradiol levels can increase thrombosis risk, particularly in the first year of treatment. The WHI studies showed increased clot risk with oral estrogen, though injectable estradiol appears safer.

Without context about her baseline levels, administration route, or clinical symptoms, viewers can't learn much from her experience. Hormone management is highly individual and depends on factors like age, route of administration, and individual metabolism.

What should transgender patients actually know about monitoring?

Regular lab monitoring is essential during transgender hormone therapy. The University of California San Francisco guidelines recommend checking estradiol levels 3 months after starting or changing doses, then every 6-12 months once stable.

Target ranges aren't one-size-fits-all. Some patients feel better with levels in the lower part of the typical range, while others need higher levels for feminization and mood stability.

Patients should work with experienced providers who understand transgender care. Dose adjustments should be based on both lab values and clinical symptoms, not social media experiences. What works for one person may not work for another, and copying someone else's dosing can be dangerous.